These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7862624)

  • 21. p53-dependent induction of WAF1 by cold shock in human glioblastoma cells.
    Ohnishi T; Wang X; Ohnishi K; Takahashi A
    Oncogene; 1998 Mar; 16(11):1507-11. PubMed ID: 9525749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.
    Gurova KV; Rokhlin OW; Budanov AV; Burdelya LG; Chumakov PM; Cohen MB; Gudkov AV
    Cancer Res; 2003 Jun; 63(11):2905-12. PubMed ID: 12782597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.
    Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T
    Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p53 gene and its role in human brain tumors.
    Bögler O; Huang HJ; Kleihues P; Cavenee WK
    Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
    Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
    Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule.
    Biroccio A; Bufalo DD; Ricca A; D'Angelo C; D'Orazi G; Sacchi A; Soddu S; Zupi G
    Gene Ther; 1999 Jun; 6(6):1064-72. PubMed ID: 10455409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells.
    Van Meir EG; Polverini PJ; Chazin VR; Su Huang HJ; de Tribolet N; Cavenee WK
    Nat Genet; 1994 Oct; 8(2):171-6. PubMed ID: 7531056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity.
    Kawamura M; Yamashita T; Segawa K; Kaneuchi M; Shindoh M; Fujinaga K
    Oncogene; 1996 Jun; 12(11):2361-7. PubMed ID: 8649776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic instability leads to loss of both p53 alleles in a human glioblastoma.
    Albertoni M; Daub DM; Arden KC; Viars CS; Powell C; Van Meir EG
    Oncogene; 1998 Jan; 16(3):321-6. PubMed ID: 9467957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
    Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis.
    Reichert M; Steinbach JP; Supra P; Weller M
    Cancer; 2002 Sep; 95(5):1113-9. PubMed ID: 12209698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
    Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
    Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.
    Tian XX; Chan JY; Pang JC; Chen J; He JH; To TS; Leung SF; Ng HK
    Br J Cancer; 1999 Nov; 81(6):994-1001. PubMed ID: 10576656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.